Literature DB >> 18577273

Diagnostic delays in vestibular schwannoma.

H Teppo1, J Heikkinen, K Laitakari, O-P Alho.   

Abstract

OBJECTIVES: The literature on delays in vestibular schwannoma diagnosis is from the era before the routine use of magnetic resonance imaging. We evaluated such diagnostic delays and their impact on tumour size and on pre- and post-treatment morbidity, in a relatively recent patient series. STUDY
DESIGN: Retrospective review.
METHODS: A two-centre study was conducted, including 91 consecutive vestibular schwannoma patients diagnosed between 1992 and 2006. Data on the presenting symptom and the initial medical visit were obtained from primary care records completed at the time of the initial visit; data on the tumour and the clinical course were obtained from review of the hospital chart. Data on diagnostic delays were available for 59 patients.
RESULTS: The median patient, professional and total diagnostic delays were three, four and 14 months, respectively. Unilateral hearing loss as the presenting symptom predicted an lengthened total diagnostic delay. Diagnostic delay had no impact on the tumour size at time of diagnosis or on the pre- and post-treatment morbidity.
CONCLUSIONS: Delays in the diagnosis of vestibular schwannoma have shortened since the introduction of magnetic resonance imaging. Longer diagnostic delays do not seem to have significant consequences.

Entities:  

Mesh:

Year:  2008        PMID: 18577273     DOI: 10.1017/S0022215108003113

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  6 in total

1.  Rule 3,000: a more reliable precursor to perceive vestibular schwannoma on MRI in screened asymmetric sensorineural hearing loss.

Authors:  Issam Saliba; Mathieu Bergeron; Geneviève Martineau; Miguel Chagnon
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-11       Impact factor: 2.503

2.  Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.

Authors:  Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

3.  Sociodemographic factors and vestibular schwannoma: a Danish nationwide cohort study.

Authors:  Joachim Schüz; Marianne Steding-Jessen; Søren Hansen; Sven-Eric Stangerup; Per Cayé-Thomasen; Christoffer Johansen
Journal:  Neuro Oncol       Date:  2010-11-10       Impact factor: 12.300

4.  Vestibular schwannoma removal through expanded transcanal transpromontorial approach: a multicentric experience.

Authors:  Giulia Molinari; Federico Calvaruso; Livio Presutti; Daniele Marchioni; Matteo Alicandri-Ciufelli; Filippo Friso; Ignacio Javier Fernandez; Pietro Francoli; Flavia Di Maro
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-08       Impact factor: 3.236

Review 5.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

6.  Management of Sporadic Vestibular Schwannomas in Children-Volumetric Analysis and Clinical Outcome Assessment.

Authors:  Julian Zipfel; Mykola Gorbachuk; Isabel Gugel; Marcos Tatagiba; Martin U Schuhmann
Journal:  Children (Basel)       Date:  2022-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.